LakeShore Biopharma Co (LakeShore Biopharma Co) Accounts Receivable : $58.84 Mil (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. LakeShore Biopharma Co's accounts receivables for the quarter that ended in Sep. 2023 was $58.84 Mil.

Accounts receivable can be measured by Days Sales Outstanding. LakeShore Biopharma Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 was 286.93.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. LakeShore Biopharma Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was $-0.54.

LakeShore Biopharma Co Accounts Receivable Historical Data

The historical data trend for LakeShore Biopharma Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Accounts Receivable Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Accounts Receivable

32.95

48.63

67.20

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Accounts Receivable	Get a 7-Day Free Trial			-	48.63	66.72	67.20	58.84

LakeShore Biopharma Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

LakeShore Biopharma Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

LakeShore Biopharma Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	58.835	/	37.421	*	91
=	286.93

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), LakeShore Biopharma Co's accounts receivable are only considered to be worth 75% of book value:

LakeShore Biopharma Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(35.614	+	0.75 * 58.835	+	0.5 * 29.162	-	144.451
-	0	-	0)	/	93.0582
=	-0.54

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

LakeShore Biopharma Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.